History of Stereotactic Surgery in France

  • A. L. Benabid
  • S. Chabardes
  • E. Seigneuret

Abstract

The history of stereotaxy is part of a larger perspective of a methodological approach that is therapeutic and focuses on the search for precision. The search for precision implies the recognition and marking of targets (taxonomic version of the etymology of the word Stereotaxy, from taxis: order) as well as to the tactic act, which is the achievement, at least in human stereotaxy, of this approach (tactic version of the etymology of the word stereotaxy). The common denominator of these two definitions is the space (from the Greek Stereos: solid, volume), which by itself would define the methodology, based on the spatial coordinates of a point that will be called the target. This etymological duality corresponds in fact to a historical perspewctive, as for the first time, in 1917, the need to precisely recognize and localize the various spatial structures of the brain led Horsley and Clark [1] to design an instrumental method aimed at quantifying cerebral space, in order to attribute precise coordinates to the different structures that the anatomo physiologists were studying at that time. This taxonomy approach led to the development of an instrument and a method, and then to the elaboration of the concept of the surgical act based on exact location. This corresponded in fact to the tactic version of the etymological definition of stereotaxy, even if it has been, historically, only secondary. Having designed an apparatus and developed a method, one tended to build on these two concrete elements a philosophy, or at least a state of mind. This constitutes the most interesting, maybe the most noble, part of the history of stereotaxy. This history has been the reflection of the complex interaction, depending upon circumstances, between the technical means of the moment and the therapeutic needs, as well as on pharmacological alternatives. This process is not specific to stereotaxy. It characterizes every approach of Homo Faber, which tries to solve his current problems, on the bases of the know-how which is available. He often stumbles on technological bottlenecks, which impede the development of methods, and even make it transitorily disappear, until the advance of knowledge in other domains provides the key, which will open the lock. A new momentum of development is therefore observed until the time when a new obstacle stops the process again, or when the need disappears, often because advancements of knowledge in other domains have brought more satisfactory solutions. Stereotaxy is at the crossroads of industrial technology, of surgical technology and therapeutic needs, themselves strongly enclosed in the domain of neurosciences, which, as we know, is undergoing rapid evolution. It is therefore not surprising to see that its history has been chaotic, and it can be foreseen that it will become even more complicated.

References

  1. 1.
    Horsley V, Clarke RH. The structure and functions of the cerebellum examined by a new method. Brain 1908;31:45–124.Google Scholar
  2. 2.
    Remy M, Contremoulins M. Le chercheur de projectiles, L’Illustration1897;55423Google Scholar
  3. 3.
    Zernov DN. Encephalometer: device for estimation of parts of brain in human. Proc Soc Physicomed Moscow Univ 1889;2:70–80.Google Scholar
  4. 4.
    Altukhov NV. Encephalometric investigations of the brain relative to the age, sex and skull indexes. Moscow; 1891.Google Scholar
  5. 5.
    Picard C, Olivier A, Bertrand G. The first human stereotaxic apparatus: The contribution of Aubrey Mussen to the field of stereotaxis. J Neurosurg 1983;59:673–6.PubMedGoogle Scholar
  6. 6.
    Olivier A, Bertrand G, Picard C. Discovery of the first human stereotactic instrument. Appl Neurophysiol 1983;46:84–91.PubMedGoogle Scholar
  7. 7.
    Spiegel EA, Wycis HT, Marks M, et al. Stereotactic apparatus for operations on the human brain. Science 1947;106:349–50.PubMedGoogle Scholar
  8. 8.
    Sedan R, Duparet R. Steréometre adaptable au cadre stéréotaxique de J Talairach. Neurochirurgie 1968;14:577–82.PubMedGoogle Scholar
  9. 9.
    Fenelon F, Thiebaut F. Résultats du traitement neurochirurgical d’une rigidité parkinsonienne par intervention striopallidale unilatérale. Rev Neurol 1950;83:280.Google Scholar
  10. 10.
    Fenelon F. Essai de traitement neurochirurgical du syndrome parkinsonien par intervention directe sur les voies extrapyramidales immédiatement sous-striopallidales (anses lenticulaires). Rev Neurol 1950;83:580–5.Google Scholar
  11. 11.
    Guiot G Brion S.“[Neurosurgery of choreoathetosic and Parkinsonian syndromes].” Sem Hop 1952;28(49):2095–9.PubMedGoogle Scholar
  12. 12.
    Guiot G, Hardy J, Albe-Fessard D. Délimitation précise des structures sous-corticales et identification de noyaux thalamiques chez l’homme par l’électrophysiologie stéréotaxique. Neurochirurgia 1962;5:1–18PubMedGoogle Scholar
  13. 13.
    Guiot G, Derome P, Trigo JC. Le tremblement d’attitude: indication la meilleure de la chirurgie stéreotaxique. Presse Med 1967;75:2513–8PubMedGoogle Scholar
  14. 14.
    Petit-Dutaillis, D., MessimyR, et al. “[Effect of prefrontal leucotomy on the behaviour of a maniac].” Rev Neurol (Paris) 1950;82(1):57–60.Google Scholar
  15. 15.
    Gros C,Vlahovitch B.“[Hemispherectomies; neurophysiological considerations].” Rev Neurol (Paris) 1951;85(6):482–4.Google Scholar
  16. 16.
    Gros C, Vlahovitch B, et al. “[Effects of prefrontal interventions (leukotomy, topectomy) on psychic and kinetic manifestations of Parkinson syndrome].” Sem Hop 1955;31(32):1831–2.PubMedGoogle Scholar
  17. 17.
    Mazars G, Rogé R, Mazars Y. Résultats de la stimulation du faisceau spino-thalamique et leur incidence sur la physiopathologie de la douleur. Revue Neurol 1960;20:136–8.Google Scholar
  18. 18.
    Mazars G, Merienne L, Cioloca G. Stimulations thalamiques intermittentes antalgiques. Revue Neurol 1973;128(4):273–9Google Scholar
  19. 19.
    Mazars G, Merienne L, et al. “[Use of thalamic stimulators in the treatment of various types of pain].” Ann Med Interne (Paris) 1975;126(12):869–71.Google Scholar
  20. 20.
    Mazars G. Intermittent stimulation of nucleus ventralis posterolateralis for intractable pain. Surg Neurol 1975;4:93–5.PubMedGoogle Scholar
  21. 21.
    Mazars G, Merienne L, et al. “[Present state of pain surgery].” Neurochirurgie 1976;22 Suppl 1:5–164.PubMedGoogle Scholar
  22. 22.
    Mazars G, Merienne L, et al. “[Effects of so-called periaqueductal gray substance stimulation].” Neurochirurgie 1979;25(2):96–100.PubMedGoogle Scholar
  23. 23.
    Mazars G, Merienne L, Cioloca G. Control of dyskinesias due to sensory deafferentation by means of thalamic stimulation. Acta Neurochirurgica Suppl (Wien) 1980;30:239–43.PubMedGoogle Scholar
  24. 24.
    Merienne L, Mazars G. Modification du schéma corporel sous stimulation thalamique. A propos des stimulations thalamiques pour membre fantômes douloureux. Neurochirurgie 1981;27:121–3.PubMedGoogle Scholar
  25. 25.
    Fenelon F. “[Neurosurgery of parkinsonian syndrome by direct intervention on the extrapyramidal tracts immediately below the lenticular nucleus. Communication followed by film showing patient before and after intervention].” Rev Neurol (Paris) 1950;83(5):437–40.Google Scholar
  26. 26.
    Fenelon F. Bilan de quatre années de pratique d’une intervention personnelle pour maladie de Parkinson. Rev Neurol 1953;89:580–5.PubMedGoogle Scholar
  27. 27.
    Guiot G, Brion S. Traitement des mouvements anormaux pour la coagulation pallidale. Technique et résultats. Rev Neurol 1953;89:578–80.PubMedGoogle Scholar
  28. 28.
    Gros C, Vlahovitch B, et al. “[the “Target” Zone in the Surgery of Parkinson’s Disease (Study of a Series of 407 Stereotaxic Operations)].” Neurochirurgie 1964;10:413–26.PubMedGoogle Scholar
  29. 29.
    Talairach J, Tournoux P.“[Apparatus for hypophysial stereotaxis by nasal approach].” Neurochirurgie 1955;1(1):127–31.PubMedGoogle Scholar
  30. 30.
    Szikla G, Talairach J.“Coordinates of the rolandic sulcus and topography of cortical and subcortical motor responses to low frequency stimulation in a proportional stereotaxic system.” Confin Neurol 1965;26(3):471–5.PubMedGoogle Scholar
  31. 31.
    Szikla G, Bouvicr G, Hori T, Petrov V. Angiography of the human brain cortex. New York: Springer; 1977.Google Scholar
  32. 32.
    Talairach J, David M, Tournoux P, et al. Atlas d’anatomie stereotaxique des noyaux gris centraux. Paris: Masson; 1957.Google Scholar
  33. 33.
    Talairach J, Szikla G, Tournoux P, et al. Atlas d’anatomie stereotaxique du telencephale. Paris: Masson; 1967.Google Scholar
  34. 34.
    Talairach J, Tournoux P. Coplanar stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging. Stuttgart: Thieme Medical Publishers; 1988.Google Scholar
  35. 35.
    Albe-Fessard D, Arfel G, Guiot G, et al. Dérivation d’activités spontanées et évoquées dans les structures cérébrales profondes de l’homme. Rev Neurol 1962;2:89–105.Google Scholar
  36. 36.
    Albe-Fessard D, Arfel G, Guiot G. Activités électriques caractéristiques de quelques structures cérébrales chez l’homme. Ann Chir 1963;17:1185–214.PubMedGoogle Scholar
  37. 37.
    Talairach J, Hecaen H, David M, et al. Recherches sur la coagulation thérapeutique des structures sous-corticales chez l’homme. Rev Neurol 1949;81:4–24.Google Scholar
  38. 38.
    Talairach J, Tournoux P, Szikla G, et al. Traitement de la maladie de Parkinson: remarques méthodologiques et technique chirurgicale. Gaz Med 1961;2:76–91.Google Scholar
  39. 39.
    Benabid A, Pollak P, Louveau A, et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson’s disease. Appl Neurophysiol 1987;50:344–6.PubMedGoogle Scholar
  40. 40.
    Benabid A, Pollak P, Gervason C, et al. Long term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403–6.PubMedGoogle Scholar
  41. 41.
    Benabid A, Pollak P, Gao D, et al. Long term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1996;84:203–14.PubMedGoogle Scholar
  42. 42.
    Blond S, Caparros-Lefebvre D, Parker F. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62–8.PubMedGoogle Scholar
  43. 43.
    Caparros-Lefebvre D, Blond S, Vermersch P, et al. Chronic thalamic stimulation improves tremor and levodopa induceddyskinesias in Parkinson’s disease. J Neurol Neurosurg Psych 1993;56:268–73.Google Scholar
  44. 44.
    Limousin P, Pollak P, Benazzouz A, et al. Effect on Parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation.Lancet 1995;345(8942):91–5.PubMedGoogle Scholar
  45. 45.
    Siegfried J. Effets de la stimulation du noyau sensitif du thalamus sur les dyskinésies et la spasticité. Rev Neurol (Paris) 1986;142:380–3.Google Scholar
  46. 46.
    Siegfried J, Lippitz B. Chronic electrical stimulation of the globus pallidus in Parkinson’s disease. Acta Neurochir 1993;124:14–18.Google Scholar
  47. 47.
    Tasker RR. Effets sensitifs et moteurs de la stimulation thalamique chez l’homme. Applications cliniques. Rev Neurol (Paris) 1986;142:316–26.Google Scholar
  48. 48.
    Adams J, Hosobuchi Y, Fields H. Stimulation of internal capsule for relief of chronic pain. J Neurosurg 1974;41:740–4.PubMedGoogle Scholar
  49. 49.
    Hosobuchi Y, Adams J, Rutkins B. Chronic thalamic stimulation for the control of facial anesthesia dolorosa. Arch Neurol 1973;29:158–61.PubMedGoogle Scholar
  50. 50.
    Talairach J, deAJ, et al. “[Therapeutic sub-cortical coagulations; topographic study of the ventricular system in relation to the central gray nuclei].” Presse Med 1950;58(38):697–701.PubMedGoogle Scholar
  51. 51.
    Talairach J, De Aljuriaguerra J, et al. “[A stereotaxic study of the deep encephalic structures in man; technic; physiopathologic and therapeutic significance.].” Presse Med 1952;60(28):605–9.PubMedGoogle Scholar
  52. 52.
    Talairach J. “[Destruction of the anterior ventral thalamic nucleus in the treatment of mental diseases].” Rev Neurol (Paris) 1952;87(4):352–7.Google Scholar
  53. 53.
    Talairach J, Tournoux P.“[Stereotaxic localization of central gray nuclei].” Neurochirurgia (Stuttg) 1958;1(1):88–93.Google Scholar
  54. 54.
    Talairach J, Tournoux P, et al. “[Parietal surgery of pain].” Acta Neurochir (Wien) 1960;8:153–250.Google Scholar
  55. 55.
    Talairach J, Ruggiero G, et al. “A new method of treatment of inoperable brain tumours by stereotaxic implantation of radioactive gold; a preliminary report.” Br J Radiol 1955;28(326):62–74.PubMedGoogle Scholar
  56. 56.
    Talairach J, Szikla G, et al. “[Stereotaxic destruction of the nontumoral hypophysis by radioactive isotopes. (Hypophysectomy for hormone-dependent cancer. Interstitial radiotherapy for malignant exphthalmos and Cushing’s syndrome of high origin)].” Presse Med 1962;70:1399–402.PubMedGoogle Scholar
  57. 57.
    Talairach J, Szikla G, et al. “[Pituitary sterotaxic surgery].” Confin Neurol 1962;22:204–16.PubMedGoogle Scholar
  58. 58.
    Talairach J, Bonis A, et al. “[Technic and results of interstitial radiotherapy of the pituitary in various endocrine syndromes: chromophobe adenoma, acromegaly and Cushing’s disease].” Acta Isot (Padova) 1964;4(4):355–85.Google Scholar
  59. 59.
    Talairach J, Szikla G.“[Amygdalo-hippocampal partial destruction by yttrium-90 in the treatment of certain epilepsies of rhinencephalic manifestation].” Neurochirurgie 1965;11(3):233–40.PubMedGoogle Scholar
  60. 60.
    Talairach J Szikla G.“[Intrasellar application of radioactive isotopes from a functional standpoint (mammary carcinoma, malignant, exophthalmos, Cushing’s syndrome, diabetes, malignant arterial hypertension)].” Nucl Med (Stuttg) 1965;:2:Suppl 371+.Google Scholar
  61. 61.
    Talairach J, Szikla G, et al. “Therapeutic utilization of radioactive isotopes in pituitary surgery.” Int J Neurol 1965;5(1):78–93.PubMedGoogle Scholar
  62. 62.
    Betti O, Derechinsky V.“[Multiple-beam stereotaxic irradiation].” Neurochirurgie 1983;29(4):295–8.PubMedGoogle Scholar
  63. 63.
    Bancaud J, Talairach J.“[Epilepsy of the supplementary motor area: a particularly difficult diagnosis in children].” Rev Neuropsychiatr Infant 1965;13(6):483–99.PubMedGoogle Scholar
  64. 64.
    Bancaud J, Talairach J.“[Methodology of stereo EEG exploration and surgical intervention in epilepsy].” Rev Otoneuroophtalmol 1973;45(4):315–28.PubMedGoogle Scholar
  65. 65.
    Talairach J, Bancaud J, et al. “[New approach to the neurosurgery of epilepsy. Stereotaxic methodology and therapeutic results. 1. Introduction and history].” Neurochirurgie; 19741:20 Suppl 1–240.Google Scholar
  66. 66.
    Talairach J, Szikla G.“Application of stereotactic concepts to the surgery of epilepsy.” Acta Neurochir Suppl (Wien) 1980;30:35–54.Google Scholar
  67. 67.
    Talairach J, Tournoux P, et al. “Stereotaxic exploration in frontal epilepsy.” Adv Neurol 1992;57:651–88.PubMedGoogle Scholar
  68. 68.
    Talairach J, Bancaud J, et al. “Surgical therapy for frontal epilepsies.” Adv Neurol 1992;57:707–32.PubMedGoogle Scholar
  69. 69.
    Mondragon S, Lamarche M.“Suppression of motor seizures after specific thalamotomy in chronic epileptic monkeys.” Epilepsy Res 1990;5(2):137–45.PubMedGoogle Scholar
  70. 70.
    Benabid AL, Minotti L, Koudsie A, de Saint Martin A, Hirsch E. Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30-month follow-up: technical case report. Neurosurgery 2002;50(6):1385–91; discussion 1391-92.PubMedGoogle Scholar
  71. 71.
    Chabardes S, Kahane P, Minotti L, Koudsie A, Hirsch E, Benabid AL. Deep brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic Disord 2002;4 Suppl 3:83–93.Google Scholar
  72. 72.
    MazarsMazars G. “[Surgical treatment of Parkinson’s disease].” Gaz Med Fr 1959;66(12):1063–4.Google Scholar
  73. 73.
    Mazars G, Droguet P, et al. “[Volitional dyskinesia of posture. Disappearance of the dyskinesia after thalamic coagulation].” Rev Prat 1960;103:73–4.PubMedGoogle Scholar
  74. 74.
    Mazars G, Pansini A, et al. “[Homolateral responses caused by stimulation of the radiating crown and of the internal capsule].” Rev Prat 1960;103:134–6.PubMedGoogle Scholar
  75. 75.
    Mazars G, Pansini A, et al. “[Contribution to the knowledge of the relations between the lesions produced by surgery of dyskinesias and the principal motor tract].” Rev Prat 1961;104:433–6.PubMedGoogle Scholar
  76. 76.
    Mazars G, Chodkiewicz JP, et al. “[The cephalogyric contingent of the cortico-capsular fibers].” Rev Neurol (Paris) 1965;112(6):553–7.Google Scholar
  77. 77.
    Mazars G, Chodkiewicz JP, et al. “[Nosology and therapeutic indications in cervico-cephalic dyskinesias].” Rev Neurol (Paris) 1967;116(5):441–3.Google Scholar
  78. 78.
    Mazars G, Merienne L, et al. “[Surgery of cephalic orientation dyskinesia].” Neurochirurgie 1968;14(6):745–52.PubMedGoogle Scholar
  79. 79.
    Mazars G, Merienne L, et al. “[Dyskinesias of the upper limb associated with dyskinesias of cephalic orientation. Study of 45 cases and presentation of a film].” Rev Neurol (Paris) 1970;122(4):275–7.Google Scholar
  80. 80.
    Merienne L, Mazars G. Traitement de certaines dyskinésies par stimulation thalamique intermittente. Neurochirurgie 1982;28:201–6.PubMedGoogle Scholar
  81. 81.
    Hassler R, Riechert T, Mundinger F, Umbach W, Ganglberger J. Physiological observations in stereotaxic operations inextrapyramidal motor disturbances. Brain 1960;83:337–51.PubMedGoogle Scholar
  82. 82.
    Svennilson E, Torvik A, Lowe R, et al. Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr Neurol Scand 1960;35:359–77.Google Scholar
  83. 83.
    Kelly PJ, Gillingham FJ. The long-term results of stereotacticsurgery and L-dopa therapy in patients with Parkinson’s disease. A 10-year follow-up study. J Neurosurg 1980;53:332–7.PubMedGoogle Scholar
  84. 84.
    Cooper IS, Bravo GI. Chemopallidectomy, and chemothalamectomy. J Neurosurg 1958;15:244–56.PubMedGoogle Scholar
  85. 85.
    Cooper IS. Surgical treatment of parkinsonism. Ann Rev Med 1965;16:309–30.PubMedGoogle Scholar
  86. 86.
    Narabayashi H, Okuma T. Procaine oil blocking of the globuspallidus for treatment of rigidity and tremor of parkinsonism:preliminary report. Proc Jpn Acad 1953;29:134.Google Scholar
  87. 87.
    Narabayashi H, Yokoshi F, Nakajiina Y. Levodopa induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatr 1984;47:831–9.PubMedGoogle Scholar
  88. 88.
    Ohye C, Maeda T, Narabayashi H. Physiologically defined VIM nucleus: its special reference to control of tremor. AppliedNeurophysiol 1976;39:285–95.Google Scholar
  89. 89.
    Backlund E, Granberg P, Hamberger B, et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J Neurosurg 1985;62:169–73.PubMedGoogle Scholar
  90. 90.
    Björklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 1979;177:555–60.PubMedGoogle Scholar
  91. 91.
    Björklund A, Stenevi U, Dunnett S. Functional reactivation the deafferented neostriatum by nigral transplant. Nature 1981;289:497–9.PubMedGoogle Scholar
  92. 92.
    Bjorklund A, Dunnett SB, et al. “Neural transplantation for the treatment of Parkinson’s disease.” Lancet Neurol 2003;2(7):437–45.PubMedGoogle Scholar
  93. 93.
    Peschanski’s team Bachoud-Levi AC, Hantraye P, et al. “Prospectives for cell and gene therapy in Huntington’s disease.” Prog Brain Res 1998;117:511–24.PubMedGoogle Scholar
  94. 94.
    Bachoud-Levi AC, Remy P, et al. “Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation.” Lancet 2000;356(9246):1975–9.PubMedGoogle Scholar
  95. 95.
    Bachoud-Levi AC, DeglonN, et al. “Neuroprotective gene therapy for Huntington’s disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF.” Hum Gene Ther 2000;11(12):1723–9.PubMedGoogle Scholar
  96. 96.
    Bachoud-Levi AC, Gaura V, et al. “Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study.” Lancet Neurol 2006;5(4):303–9.PubMedGoogle Scholar
  97. 97.
    Peschanski M, Rudin M, et al. “Magnetic resonance imaging of intracerebral neural grafts.” Prog Brain Res 1988;78:619–24.PubMedGoogle Scholar
  98. 98.
    Peschanski M, Defer G, et al. “Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson’s disease following intrastriatal transplantation of foetal ventral mesencephalon.” Brain 1994;117 (Pt 3):487–99.PubMedGoogle Scholar
  99. 99.
    Peschanski M. “The breaking of embargoes.” Lancet 2001;357(9260):963.PubMedGoogle Scholar
  100. 100.
    Peschanski M, Dunnett SB.“Cell therapy for Huntington’s disease, the next step forward.” Lancet Neurol 2002;1(2):81.PubMedGoogle Scholar
  101. 101.
    Peschanski M, Bachoud-Levi AC, et al. “Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington’s disease.” Brain 2004;127(Pt 6):1219–28.PubMedGoogle Scholar
  102. 102.
    Peschanski M. “[Stem cells, time for scale-up].” Med Sci (Paris) 2008;24(4):335–7.Google Scholar
  103. 103.
    Lefaucheur JP, Menard-Lefaucheur I, et al. “Electrophysiological deterioration over time in patients with Huntington’s disease.” Mov Disord 2006;21(9):1350–4.PubMedGoogle Scholar
  104. 104.
    Levivier M, Dethy S, et al. “Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson’s disease. Methodology and 6-month to 1-year follow-up in 3 patients.” Stereotact Funct Neurosurg 1997;69(1–4 Pt 2):99–111.PubMedGoogle Scholar
  105. 105.
    Mitjavila-Garcia MT, Simonin C, et al. “Embryonic stem cells: meeting the needs for cell therapy.” Adv Drug Deliv Rev 2005;57(13):1935–43.PubMedGoogle Scholar
  106. 106.
    Palfi S, Ferrante RJ, et al. “Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington’s disease.” J Neurosci 1996;16(9):3019–25.PubMedGoogle Scholar
  107. 107.
    Peltekian E, Parrish E, et al. “Adenovirus-mediated gene transfer to the brain: methodological assessment.” J Neurosci Methods 1997;71(1):77–84.PubMedGoogle Scholar
  108. 108.
    Cesaro P, Peschanski M, et al. “Treatment of Parkinson’s disease by cell transplantation.” Funct Neurol 2001;16(1):21–7.PubMedGoogle Scholar
  109. 109.
    Cochen V, Ribeiro MJ, et al. “Transplantation in Parkinson’s disease: PET changes correlate with the amount of grafted tissue.” Mov Disord 2003;18(8):928–32.PubMedGoogle Scholar
  110. 110.
    Bloch J, Bachoud-Levi AC, et al. “Neuroprotective gene therapy for Huntington’s disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.” Hum Gene Ther 2004;15(10):968–75.PubMedGoogle Scholar
  111. 111.
    Laitinen LV, Bergenheim AT, Hariz MI. Leksell’s posteroventral pallidotomy in the treatment of Parkinson’s disease. J Neurosurg 1992;76:53–61.PubMedGoogle Scholar
  112. 112.
    Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337(8738):403–6.PubMedGoogle Scholar
  113. 113.
    Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med;1998;339(16):1105–11.PubMedGoogle Scholar
  114. 114.
    Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five years follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003;349:1925–34.PubMedGoogle Scholar
  115. 115.
    Gros C, Vlahovitch B, et al. “[Personal experience with surgery of pain in cancer].” J Radiol Electrol Arch Electr Medicale 1955;36(7–8):618–20.PubMedGoogle Scholar
  116. 116.
    Blond S, Siegfried J.“Thalamic stimulation for the treatment of tremor and other movement disorders.” Acta Neurochir Suppl (Wien) 1991;52:109–11.Google Scholar
  117. 117.
    Tsubokawa T, Katayama Y, et al. “Chronic motor cortex stimulation for the treatment of central pain.” Acta Neurochir Suppl (Wien) 1991;52:137–9.Google Scholar
  118. 118.
    Nguyen JP, Lefaucher JP, Le Guerinel C, Eizenbaum JF, Nakano N, Carpentier A, et al. “Motor cortex stimulation in the treatment of central and neuropathic pain.” Arch Med Res 2000;31(3):263–5.PubMedGoogle Scholar
  119. 119.
    Garcia-Larrea L, Peyron R. Motor cortex stimulation for neuropathic pain: From phenomenology to mechanisms.” Neuroimage 2007;37 Suppl 1:S71–9.PubMedGoogle Scholar
  120. 120.
    Lazorthes Y, Sol JC, Fowo S, Roux FE, Verdie JC. “Motor cortex stimulation for neuropathic pain.” Acta Neurochir Suppl 2007;97(Pt 2):37–44.PubMedGoogle Scholar
  121. 121.
    Benabid AL, Hoffmann D, Lavallee S, Cinquin P, Demongeot J, Lebas JF, et al. Is there any future for robots in neurosurgery? In: SymonL, editors. Advances and Technical Standards in Neurosurgery, vol. 18. Springer: Wien New York; p. 3–45Google Scholar
  122. 122.
    Kelly PJ, Alker GJ. A method for stereotactic laser microsurgery in the treatment of deep seated CNS neoplasms. Appl Neurophysiol 1980;43:210–15.PubMedGoogle Scholar
  123. 123.
    Young RJ. Application of robotics to stereotactic neurosurgery. Neurol Res 1887;9:123–8.Google Scholar
  124. 124.
    Mallet L, Mesnage V, et al. “Compulsions, Parkinson’s disease, and stimulation.” Lancet 2002;360(9342):1302–4.PubMedGoogle Scholar
  125. 125.
    Cohadon F,Richer E. “[Post-traumatic vegetative states].” Neurochirurgie 1993;39(5):269–80.PubMedGoogle Scholar
  126. 126.
    Cohadon F, Richer E. “[Deep cerebral stimulation in patients with post-traumatic vegetative state. 25 cases].” Neurochirurgie 1993;39(5):281–92.PubMedGoogle Scholar
  127. 127.
    Tsubokawa T, Yamamoto T, et al. “Deep-brain stimulation in a persistent vegetative state: follow-up results and criteria for selection of candidates.” Brain Inj 1990;4(4):315–27.PubMedGoogle Scholar
  128. 128.
    Yamamoto T, Katayama Y, et al. “Deep brain stimulation therapy for a persistent vegetative state.” Acta Neurochir Suppl 2002;79:79–82.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • A. L. Benabid
  • S. Chabardes
  • E. Seigneuret

There are no affiliations available

Personalised recommendations